PCA
CVS icon

Personal Capital Advisors’s CVS Health CVS Stock Holding History

Personal Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$60.3M Buy
647,077
+9,424
+1% +$909K 0.29% 80
2022
Q3 		$60.8M Buy
637,653
+6,091
+1% +$603K 0.33% 71
2022
Q2 		$58.5M Buy
631,562
+8,573
+1% +$837K 0.31% 75
2022
Q1 		$63.1M Buy
622,989
+6,382
+1% +$670K 0.29% 80
2021
Q4 		$63.7M Buy
616,607
+9,717
+2% +$898K 0.29% 79
2021
Q3 		$51.5M Buy
606,890
+22,014
+4% +$1.84M 0.26% 93
2021
Q2 		$48.8M Buy
584,876
+27,316
+5% +$2.24M 0.25% 98
2021
Q1 		$41.9M Buy
557,560
+35,800
+7% +$2.61M 0.24% 99
2020
Q4 		$35.6M Buy
521,760
+64,193
+14% +$4.18M 0.23% 99
2020
Q3 		$26.7M Sell
457,567
-67,037
-13% -$4.17M 0.2% 101
2020
Q2 		$34.1M Sell
524,604
-5,112
-1% -$322K 0.28% 85
2020
Q1 		$31.3M Sell
529,716
-187,052
-26% -$12.5M 0.31% 75
2019
Q4 		$53.2M Buy
716,768
+20,734
+3% +$1.46M 0.45% 47
2019
Q3 		$43.9M Buy
696,034
+41,325
+6% +$2.45M 0.42% 56
2019
Q2 		$35.7M Buy
654,709
+164,874
+34% +$8.88M 0.36% 74
2019
Q1 		$26.4M Buy
489,835
+98,932
+25% +$6.11M 0.3% 86
2018
Q4 		$25.6M Buy
+390,903
New +$29.2M 0.34% 73
2018
Q2 		– Sell
-4,488
Closed -$279K – 280
2018
Q1 		$279K Sell
4,488
-257,998
-98% -$18.5M ﹤0.01% 225
2017
Q4 		$19M Sell
262,486
-14,912
-5% -$1.08M 0.32% 81
2017
Q3 		$22.6M Buy
277,398
+29,985
+12% +$2.37M 0.44% 63
2017
Q2 		$19.9M Buy
247,413
+22,600
+10% +$1.78M 0.44% 66
2017
Q1 		$17.7M Buy
224,813
+23,530
+12% +$1.88M 0.45% 71
2016
Q4 		$15.9M Sell
201,283
-10,443
-5% -$845K 0.47% 69
2016
Q3 		$19M Buy
211,726
+28,498
+16% +$2.69M 0.64% 54
2016
Q2 		$17.5M Buy
183,228
+22,857
+14% +$2.28M 0.67% 45
2016
Q1 		$16.6M Buy
160,371
+26,795
+20% +$2.61M 0.77% 36
2015
Q4 		$13.1M Buy
133,576
+8,637
+7% +$846K 0.72% 46
2015
Q3 		$12.1M Buy
124,939
+13,806
+12% +$1.45M 0.79% 36
2015
Q2 		$11.7M Buy
+111,133
New +$11.4M 0.81% 27

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Personal Capital Advisors's CVS Position: Q4 2022 in Review

Personal Capital Advisors increased its CVS Health (CVS) stake by 1.5% in Q4 2022, buying an estimated $909K and bringing the position to 647,077 shares worth $60.3M. The position accounts for 0.29% of the portfolio, ranked #80.

Personal Capital Advisors first reported a position in CVS in Q2 2015 and has held it in 29 quarters since. The position peaked at $63.7M in Q4 2021. 2,409 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • Personal Capital Advisors held 647,077 shares of CVS Health worth $60.3M as of Q4 2022.
  • Personal Capital Advisors bought 9,424 CVS Health shares in Q4 2022, an estimated $909K.
  • CVS Health made up 0.29% of Personal Capital Advisors's portfolio in Q4 2022, its #80 holding.
  • Personal Capital Advisors first reported a position in CVS Health in Q2 2015 and has held it in 29 quarters since.
  • Personal Capital Advisors's CVS Health position peaked at $63.7M in Q4 2021.
  • 2,409 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Personal Capital Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.